Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
61 Cards in this Set
- Front
- Back
Epidemiology of type II DM
|
Most common type.
Tons in Pima Indians (>40%) Many undiagnosed |
|
Will stem cell research have much benefit for type II diabetes>?
|
no, but yes for type I
|
|
Is diabetes a modifiable or unmodifiable risk factor for CAD and PAD?
|
unmod
(treating diabetes doesn't seem to lower risk of getting these) |
|
Usual dx of type II DM
|
30-40
|
|
Will pts gain or lose weight before sx of type II DM?
|
Gain
|
|
Concordance of type II DM in identical twins
|
about 100%
(type 1 is less genetic) |
|
Which diabetic needs to go to the eye doc immediately?
|
type II
because they probably have had this disease for quite some time. |
|
Labs of type II DM
|
fasting gluc > 126
glucosuria proteinuria (mild) hematuria increased VLDLs low HDLs |
|
Risk factors of type II DM
|
age>40
obesity prior gestational diab prior glucose intol fam hx Hispanic, black, american indians poor urban dwelling high sat fats |
|
with impaired gluc tol...
|
2 hour plasma gluc after 75g load is over 140 and more likely to develop type II DM
|
|
glucose tol _____ as you get older
|
decreases
|
|
simple things that help with type II DM
|
diet, lifestyle mod
|
|
Timeline of type 1 diabetes
|
hyperglycemia in the teens and in 5-6 yeras they stop making it.
by the time of dx, there is almost no insulin secretion. |
|
timeline of type 2 diabetes
|
hyperglycemia around age 30-40
during pubberty they were making more than avg insulin but then this declines AND THEN blood sugar rises. |
|
Medications of type II DM - general feature of their dosing
|
you constantly have to increase them because they work less well over time.
|
|
genes that can get busted in type II DM
|
there are many.
|
|
insulin tolerance test
|
testing how much of a drop of blood glucose you get after certain doses of insulin
|
|
HOMA calculation
|
measures insulin resistance IN POPULATIONS
measures ratio of glucose to insulin in a fasting state. |
|
frquent samples of IV glucose tolerance test
|
measures how fast glucose is removed per unit time.
|
|
Gold standard test for insulin responsiveness
|
glucose clamp technique
give a continuous fixed dose of insulin and then give enough glucose to maintain glucose concentration pts without diabetes (insulin sensitive) will need more glucose. |
|
Where is most insulin-mediated glucose disposal?
|
in the muscle.
so diminished glucose disposal rates during insulin clamp indicates a decreased response of muscle to insulin. |
|
Where does glucose go in the blood
|
80% taken up by the liver.
The rest is disposed under direction of insulin to mostly muscle, and some to fat (there is just simply more musc than fat) |
|
Worst way to measure insulin resistance
|
fasting insulin level because it is influenced by weight, age, pre-diabetes, medications, stress.
|
|
Does insulin regulat glucose input in the liver?
|
no, but it does for glucose output from the liver.
|
|
GLucose output in pts with type II DM
|
more gluconeuogenesis and glycogenolysis
|
|
What is a good measure of liver glucose output?
|
fasting glucose
|
|
insulin and fat tissue
|
insulin regulates glucose uptake by fat, but fat only takes up a little glucose after a meal.
insulin mainly regulates output of FFAs from fat cells. and high FFA levels cause/enhance insulin resistance. |
|
facts that determine hepatic glucose output
|
substrate avail (alanine, lactate, glycogen, acetyl coa)
cofactors-NADH hepatic [] of gluconeogenic enzymes glucagon, catechol, growth hormone) glycogen storage pathway enzymes |
|
islet cell phases in type II DM
|
0-normal
2-pre-diabetes and borderline beta cell mass 3-loss of insulin sensitive 4-amylin found in islets and more reduced beta cell mass 5-severe reduction in beta cell mass. |
|
as pts gain weight...
|
they acquire even more resistance to insulin which just makes everything even worse.
|
|
incretins
|
released by GI tract in response to food
augments insulin release, decreases glucagon release, slow gastric empyting. less release of incretins in pts with type II DM half life of them is very short. |
|
Glucose toxicity
|
the idea that chronic hyperglycemia leads to more insulin resistance and less insulin secretion.
|
|
clinicaly application of glucose toxicity
|
give a pt insulin to make their glycemic levels normals. so now their body is re-adjusted to having normal glycemic levels.
so you need to scale back the supplemental insulin dose or else the pt will get hypoglycemia! |
|
Pima indians
|
no obesity until forced onto reservations with provided food.
(genetically very good at storing calories) |
|
acanthosis nigricans
|
a skin disorder where it is dark like a football on neck and underarms
a good sign of insulin resistance. (type II DM) |
|
why is it so imp to determine type i vs. ii?
|
very diff tx
with i - need insulin therapy for life. |
|
diagnostic diff from type II DM and type I
|
islet cell antibodies - type i
obesity and acanthosis nigricans - type ii |
|
MODY 2 glucokinase gene (GCK)
|
on chrom 7 - aut dom
means maturity onset diabetes of the young glucokinase normally phosphorylates glucose in the islet cell and serves as the glucose sensor. with mutation, the sensor is set at a higher level. |
|
Other causes of type II DM
|
Pancreatitis via hemochromatosis (damage to islet cells)
endocrine disorders that impair insulin sensitivity - acromegaly, cushing's, pheochromocytoma endocrine disorders that inhibit insulin secretion - glucagonoma, somatostatinoma, hyperaldosteronism. |
|
Drugs that induce diabetes
|
Be esp careful with these drugs if pt with impaired glucose tolerance
prednisone, beta blockers - impair gluc sensitivity pentamidine - impair insulin release impair both release and sensitivity - cyclosporine, FK 506, thiazides increase nutrient flux - niacin, TPN. |
|
stopped flashcards at slide
|
67
|
|
resistance to insulin at muscle leads to...
|
post meal hyperglycemia
|
|
resistance to insulin at fat leads to...
|
release of FFAs
|
|
resistance to insulin at liver leads to...
|
greater hepatic glucose output
|
|
binding of insulin to receptor
|
normal in type 2 diabetes
|
|
metabolic syndrome
|
to ID people without diabetes
insulin resistance high levels of TGs low HDL levels HTN high risk of atherosclerosis. |
|
adiponectin
|
sets insulin sensitivity
levels are low in the obese and pts with type 2 diabetes |
|
amylin
|
accumulates in pts with type 2 diabetes (in the islets)
|
|
antagonist against interleukin 1...
|
called anakinra. showed improvement in pts with type 2 diabetes
made them secrete more insulin shows a role for imflammation in type 2 diabetes |
|
glp-1 released from...
|
L cells of the ileum.
|
|
gastric bypass..
|
results in increased of previously depressed levels of glp-1
|
|
which comes first? weight loss of improvement of type 2 diabetes?
|
improvement of type 2 diabetes
|
|
pts with type 2 diabetes die from...
|
accelerated macrovascular disease (e.g. atherosclerotic disease), not microvascular.
|
|
2 diet approaches
|
high complex carbs/low fat diet
high monounsat fat diet - this one has better diab control but less compliance. |
|
Unique tx goals of type II diabetes
|
Glycemia (ideally A1c<6; practically <8)
BP under 135/85 Wt reduction Minimize risk factors for atherosclerosis. |
|
Rule of thumb for conv a1c to blood gluc
|
mult by 20
|
|
two definite things to restrict in diabetic diet
|
Simple sugars and sat fats.
|
|
Role of gastric bypass
|
Immediate caloric reduction so insulin sec is better matched to intake
Less FFAs and food intake so hepatic gluc output is reduced Inc in GLP-1 levels Serves as a definite cure/delay of type II Diabetes. |
|
Tx scheme
|
Diet
exercise diabetes education |
|
chart at end of ppt and notes
|
v. important and good.
|
|
why is risk of complic greater in type i diabetics?
|
they get the disease at a younger age and have more extreme glycemic changes.
|